Bevirimat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bevirimat, covering 2010-01-20 to 2010-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days [Phase 2]